Neurocrine Biosciences
NBIX
#1498
Rank
C$20.40 B
Marketcap
C$200.71
Share price
-1.55%
Change (1 day)
2.94%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company